{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T02:21:08Z","timestamp":1713406868745},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,17]]},"DOI":"10.7759\/cureus.58450","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T11:40:42Z","timestamp":1713354042000},"source":"Crossref","is-referenced-by-count":0,"title":["An Unusual Presentation of Erythema Multiforme Following the Administration of Pfizer-BioNTech COVID-19 mRNA Vaccine in a Pediatric Patient"],"prefix":"10.7759","author":[{"given":"Yara","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad","family":"Abdulghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan F","family":"Huwait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdy","family":"Abdulghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahal J","family":"Samarkandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.09.002","article-title":"Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study","volume":"86","author":"McMahon DE","year":"2022","unstructured":"McMahon DE, Kovarik CL, Damsky W, et al.. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study. J Am Acad Dermatol. 2022, 86:113-21. 10.1016\/j.jaad.2021.09.002","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17757","article-title":"Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech)","volume":"36","author":"Kim MJ","year":"2022","unstructured":"Kim MJ, Kim JW, Kim MS, Choi SY, Na JI. Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech). J Eur Acad Dermatol Venereol. 2022, 36:e98-e100. 10.1111\/jdv.17757","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14970","article-title":"Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine","volume":"47","author":"Sechi A","year":"2022","unstructured":"Sechi A, Pierobon E, Pezzolo E, et al.. Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine. Clin Exp Dermatol. 2022, 47:437-40. 10.1111\/ced.14970","journal-title":"Clin Exp Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15894","article-title":"Atypical erythema multiforme related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine","volume":"60","author":"Buj\u00e1n Bonino C","year":"2021","unstructured":"Buj\u00e1n Bonino C, Moreiras Arias N, L\u00f3pez-Pardo Rico M, Pita da Veiga Seijo G, Ros\u00f3n L\u00f3pez E, Su\u00e1rez Pe\u00f1aranda JM, S\u00e1nchez-Aguilar Rojas D. Atypical erythema multiforme related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine. Int J Dermatol. 2021, 60:e466-7. 10.1111\/ijd.15894","journal-title":"Int J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-021-04911-4","article-title":"Erythema multiforme following COVID-19 vaccination (BNT162b2) [Article in German]","volume":"73","author":"Wunderlich K","year":"2022","unstructured":"Wunderlich K, Dirschka T. Erythema multiforme following COVID-19 vaccination (BNT162b2) [Article in German]. Hautarzt. 2022, 73:68-70. 10.1007\/s00105-021-04911-4","journal-title":"Hautarzt"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0757","article-title":"Viral-like reaction or hypersensitivity? Erythema multiforme minor reaction and moderate eosinophilia after the Pfizer-BioNTech BNT162b2 (mRNA-based) SARS-CoV-2 vaccine","volume":"32","author":"de Las Vecillas L","year":"2021","unstructured":"de Las Vecillas L, L\u00f3pez J, Morch\u00f3n E, Rodriguez F, Drake M, Martino M. Viral-like reaction or hypersensitivity? Erythema multiforme minor reaction and moderate eosinophilia after the Pfizer-BioNTech BNT162b2 (mRNA-based) SARS-CoV-2 vaccine. J Investig Allergol Clin Immunol. 2021, 32:77-8. 10.18176\/jiaci.0757","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17688","article-title":"Nevocentric erythema multiforme after SARS-COV-2 vaccine","volume":"36","author":"Scharf C","year":"2022","unstructured":"Scharf C, Di Brizzi EV, Pellerone S, Liguori M, Giorgio CM, Argenziano G. Nevocentric erythema multiforme after SARS-COV-2 vaccine. J Eur Acad Dermatol Venereol. 2022, 36:e30-2. 10.1111\/jdv.17688","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17682","article-title":"Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiforme","volume":"36","author":"Borg L","year":"2022","unstructured":"Borg L, Mercieca L, Mintoff D, Micallef D, Pisani D, Betts A, Scerri L. Pfizer-BioNTech SARS-CoV-2 mRNA vaccine-associated erythema multiforme. J Eur Acad Dermatol Venereol. 2022, 36:e22-4. 10.1111\/jdv.17682","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14714","article-title":"A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine","volume":"46","author":"Lavery MJ","year":"2021","unstructured":"Lavery MJ, Nawimana S, Parslew R, Stewart L. A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine. Clin Exp Dermatol. 2021, 46:1325-7. 10.1111\/ced.14714","journal-title":"Clin Exp Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2174\/1574886318666230725101846","article-title":"Erythema multiforme reactions following Pfizer\/BioNTech (tozinameran) vaccination: two case-reports with positive rechallenge and review of the literature","author":"Charfi O","year":"2023","unstructured":"Charfi O, Lakhoua G, Berrim K, et al.. Erythema multiforme reactions following Pfizer\/BioNTech (tozinameran) vaccination: two case-reports with positive rechallenge and review of the literature. Curr Drug Saf. 2023, 10.2174\/1574886318666230725101846","journal-title":"Curr Drug Saf"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.9544-22","article-title":"Erythema multiforme after BNT162b2 vaccination","volume":"61","author":"Katayama S","year":"2022","unstructured":"Katayama S, Ota M. Erythema multiforme after BNT162b2 vaccination. Intern Med. 2022, 61:1929. 10.2169\/internalmedicine.9544-22","journal-title":"Intern Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-022-02124-2","article-title":"Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases","volume":"22","author":"Petruzzi M","year":"2022","unstructured":"Petruzzi M, Galleggiante S, Messina S, Della Vella F. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases. BMC Oral Health. 2022, 22:90. 10.1186\/s12903-022-02124-2","journal-title":"BMC Oral Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8667-7","article-title":"Current perspectives on erythema multiforme","volume":"54","author":"Lerch M","year":"2018","unstructured":"Lerch M, Mainetti C, Terziroli Beretta-Piccoli B, Harr T. Current perspectives on erythema multiforme. Clin Rev Allergy Immunol. 2018, 54:177-84. 10.1007\/s12016-017-8667-7","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.12.047","article-title":"mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach","volume":"9","author":"Banerji A","year":"2021","unstructured":"Banerji A, Wickner PG, Saff R, et al.. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach. J Allergy Clin Immunol Pract. 2021, 9:1423-37. 10.1016\/j.jaip.2020.12.047","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang Q","year":"2015","unstructured":"Yang Q, Lai SK. Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2015, 7:655-77. 10.1002\/wnan.1339","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.12.028","article-title":"Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017","volume":"38","author":"Su JR","year":"2020","unstructured":"Su JR, Haber P, Ng CS, Marquez PL, Dores GM, Perez-Vilar S, Cano MV. Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999-2017. Vaccine. 2020, 38:1746-52. 10.1016\/j.vaccine.2019.12.028","journal-title":"Vaccine"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/240302-an-unusual-presentation-of-erythema-multiforme-following-the-administration-of-pfizer-biontech-covid-19-mrna-vaccine-in-a-pediatric-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T11:40:44Z","timestamp":1713354044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/240302-an-unusual-presentation-of-erythema-multiforme-following-the-administration-of-pfizer-biontech-covid-19-mrna-vaccine-in-a-pediatric-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.58450","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,17]]}}}